References
- Aquino V M. Acute myelogenous leukemia. Curr Probl Pediatr 2002; 32: 50–58
- Martinez-Climent J A, Lane N J, Rubin C M, Morgan E, Johnstone H S, Mick R, et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95–101
- Raimondi S C, Chang M N, Ravindranath Y, Behm F G, Gresik M V, Steuber C P, et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group Study—POG 8821. Blood 1999; 94: 3707–3716
- Forestier E, Heim S, Blennow E, Borgström G, Holmgren G, Heinonen K, et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Brit J Haematol 2003; 121: 566–577
- Stark B, Jeison M, Gabay L G, Mardoukh J, Luria D, Bar-Am I, et al. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel. Brit J Haematol 2004; 126: 320–337
- An international system for cytogenetic nomenclature, ISCN 1995, F Mitelman. S Karger, Basel 1995
- Wong K F, Kwong Y L. Isochromosome 8q is a marker of secondary acute myeloid leukemia. Cancer Genet Cytogenet 2000; 120: 171–173
- Mitelman Database of Chromosome Aberrations in Cancer, F Mitelman, B Johansson, F Mertens, 2006, http://cgap.nci.nih.gov/Chromosomes/Mitelman, accessed Dec 2006
- Litz C E, Davies S, Brunning R D, Kueck B, Parkin J L, Gajl Peczalska K, et al. Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations. Leukemia 1995; 9: 1432–1439
- Huhta T, Vettenranta K, Heinonen K, Kanerva J, Larramendy M L, Mahlamaki E, et al. Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia. Leuk Lymphoma 1999; 35: 311–315
- Meshinchi S, Woods W G, Stirewalt D L, Sweetser D A, Buckley J D, Tjoa T K, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001; 97: 89–94
- Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326–4335
- Tsirigotis P, Papageorgiou S, Abatzis D, Athanatou S, Girkas C, Pappa V, et al. Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis. Cancer Genet Cytogenet 2005; 161: 78–81